Cancer Letters
Volume 210, Issue 1 , Pages 95-100 , 8 July 2004

Expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 in colorectal cancer

  • Šárka Žbánková

      Affiliations

    • Department of Internal Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic
    • Institute of Physiology, Czech Academy of Sciences, Vı́deňská 1083, Prague 4-Krč 142 20, Czech Republic
    • ,
  • Jana Bryndová

      Affiliations

    • Institute of Physiology, Czech Academy of Sciences, Vı́deňská 1083, Prague 4-Krč 142 20, Czech Republic
    • ,
  • Milan Kment

      Affiliations

    • Department of Internal Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic
    • ,
  • Jiřı́ Pácha

      Affiliations

    • Institute of Physiology, Czech Academy of Sciences, Vı́deňská 1083, Prague 4-Krč 142 20, Czech Republic
    • Corresponding Author InformationCorresponding author. Tel.: +420-2-475-2440; fax: +420-2-475-2488

Received 25 April 2003 ,Revised 17 October 2003 ,Accepted 31 December 2003.

References 

  1. Berrada A, Denis MG, Blanchardie P, Chadeneau C, Lustenberger P. Glucocorticoid effects and receptors in two rat colon carcinoma cell lines differing by their tumorigenicity. J. Steroid Biochem. Mol. Biol. 1990;37:223–230
  2. Lointier P, Wildrick DM, Boman BM. The effects of steroid hormones on human colon cancer cell line in vitro. Anticancer Res. 1992;12:1327–1330
  3. Braunschweiger PG, Ting HL, Schiffer LM. Correlation between glucocorticoid receptor content and the antiproliferative effect of dexamethasone in experimental solid tumors. Cancer Res. 1983;43:4757–4761
  4. Arisawa Y, Sutanto-Ward E, Fortunato L, Sigurdson ER. Hepatic artery dexamethasone infusion inhibits colorectal hepatic metastases: a regional antiangiogenic therapy. Ann. Surg. Oncol. 1995;2:114–120
  5. Meyer AS, Schmidt TJ. Potential mechanisms underlying autoregulation of glucocorticoid receptor mRNA levels in the DHD/K12/PROb rat colonic adenocarcinoma cell line. J. Steroid Biochem. Mol. Biol. 1995;55:219–228
  6. Brentani MM, Liberato MH, Macedo TM, Habr-Gama A, Laudanna AA. Steroid receptors in Brazilian patients with large bowel cancer. Braz. J. Med. Biol. Res. 1993;26:277–284
  7. McCawley LJ, Matrisian LM. Tumor progression: Defining the soil round the tumor seed. Curr. Biol. 2001;11:R25–R27
  8. Rabbitt EH, Lavery GG, Walker EA, Cooper MS, Stewart PM, Hewison M. Prereceptor regulation of glucocorticoid action by 11β-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation. FASEB J. 2002;16:36–44
  9. Stewart PM, Krozowski ZS. 11β-hydroxysteroid dehydrogenase. Vit. Horm. 1999;57:249–324
  10. Whorwood CB, Ricketts ML, Stewart PM. Epithelial cell localization of type 2 11β-hydroxysteroid dehydrogenase in rat and human colon. Endocrinology. 1994;135:2533–2541
  11. Smith RE, Maguire JA, Stein-Oakley AN, Sasano H, Takahashi K, Fukushima K, et al. Localization of 11β-hydroxysteroid dehydrogenase type II in human epithelial tissues. J. Clin. Endocrinol. Metab. 1996;81:3244–3248
  12. Takahashi K, Sasano H, Fukushima K, Hirasawa G, Miura H, Sasaki I, et al.  11β-hydroxysteroid dehydrogenase type II in human colon cancer: a new marker of fetal development and differentiation in neoplasms. Anticancer Res. 1998;18:3381–3388
  13. Pácha J, Lisá V, Mikšı́k I. Effect of cellular differentiation on 11β-hydroxysteroid dehydrogenase activity in the intestine. Steroids. 2002;67:119–126
  14. Ferrari P, Smith RE, Funder JW, Krozowski ZS. Substrate and inhibitory specificity of the cloned human 11β-hydroxysteroid dehydrogenase type 2 isoform. Am. J. Physiol. 1996;270:E900–E904
  15. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 1994;105:R11–R17
  16. Gomez-Sanchez EP, Ganjam V, Chen YJ, Cox DL, Zhou M-Y, Thanigarj S, et al. The sheep kidney contains a novel unidirectional, high affinity NADP+-dependent 11β hydroxysteroid dehydrogenase (11β-HSD-3). Steroids. 1997;62:444–450
  17. Pohlová I, Mikšı́k I, Kuneš J, Pácha J. 11β-hydroxysteroid dehydrogenase activity in spontaneously hypertensive and Dahl rats. Am. J. Hypertens. 2000;13:927–933
  18. Whorwood CB, Mason JI, Ricketts ML, Howie AJ, Stewart PM. Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts. Mol. Cell. Endocrinol. 1995;110:R7–12
  19. Kreuzer KA, Lass U, Landt O, Nitsche A, Laser J, Ellerbrok H, et al.  Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of β-actin transcripts as quantitative reference. Clin. Chem. 1999;45:297–300
  20. Hundertmark S, Bühler H, Rudolf M, Weitzel HK, Ragosch V. Inhibition of 11β-hydroxysteroid dehydrogenase activity enhances the antiproliferative effect of glucocorticosteroids on MCF-7 and ZR-75-1 breast cancer cells. J. Endocrinol. 1997;155:171–180
  21. Bland R, Worker CA, Noble BS, Ryre LJ, Bujalska IJ, Sheppard MC, et al. Characterization of 11β-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines. J. Endocrinol. 1999;161:455–464
  22. Rabbitt EH, Ayuk J, Boelaert K, Sheppard MC, Hewison M, Stewart PM, et al. Abnormal expression of 11β-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation. Oncogene. 2003;22:1663–1667
  23. Mune T, Morita H, Suzuki T, Takahashi Y, Isomura Y, Tanahashi T, et al.  Role of local 11β-hydroxysteroid dehydrogenase type 2 expression in determining the phenotype of adrenal adenomas. J. Clin. Endocrinol. Metab. 2003;88:864–870
  24. Albertin G, Tortorella C, Malendowicz LK, Aragona F, Neri G, Nussdorfer GG. Human adrenal cortex and aldosterone secreting adenomas express both 11β-hydroxysteroid dehydrogenase type 1 and type 2 genes. Int. J. Mol. Med. 2002;9:495–498
  25. Mazzocchi G, Malendowicz LK, Aragona F, Tortorella C, Gottardo L, Nussdorfer GG. 11β-hydroxysteroid dehydrogenase types 1 and 2 are up- and downregulated in cortisol-secreting adrenal adenomas. J. Invest. Med. 2002;50:288–292
  26. Sasano H, Frost AR, Saitoh R, Matsunaga G, Nagura H, Krozowski ZS, et al. Localization of mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II in human breast and its disorders. Anticancer Res. 1997;17:2001–2008
  27. Thieringer R, LeGrande CB, Cai T-Q, Wong B, Wright SD, Hermanowski-Vosatka A. 11β-hydroxysteroid dehydrogenase type 1 is induced in human monocytes upon differentiation to macrophages. J. Immunol. 2001;167:30–35
  28. Maser E. Stress, hormonal changes, alcohol, food constituents and drugs: factors that advance the incidence of tobacco smoke-related cancer. Trends Pharmacol. Sci. 1997;18:270–275
  29. Eberhardt W, Schulze M, Engels C, Klasmeier E, Pfeilschifter J. Glucocorticoid-mediated suppresion of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells. Involvement of nuclear factor kappa-B and ets transcription factors. Mol. Endocrinol. 2002;16:1752–1766

PII: S0304-3835(04)00023-0

doi: 10.1016/j.canlet.2003.12.019

Cancer Letters
Volume 210, Issue 1 , Pages 95-100 , 8 July 2004

Article Tools

* Image Usage & Resolution